Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

BioGaia AB (publ)

BIOG-B
Current price
104.4 SEK -2.89 SEK (-2.70%)
Last closed 107.6 SEK
ISIN SE0017769995
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Stockholm Exchange
Capitalization 10 723 172 355 SEK
Yield for 12 month +2.35 %
1Y
3Y
5Y
10Y
15Y
BIOG-B
21.11.2021 - 28.11.2021

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden. Address: Kungsbroplan 3, Stockholm, Sweden, 112 27

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1 811.5 SEK

P/E ratio

31.7365

Dividend Yield

1.83 %

Current Year

+1 296 506 001 SEK

Last Year

+1 103 957 995 SEK

Current Quarter

+303 971 002 SEK

Last Quarter

+384 121 995 SEK

Current Year

+950 189 999 SEK

Last Year

+801 930 000 SEK

Current Quarter

+222 335 005 SEK

Last Quarter

+284 040 999 SEK

Key Figures BIOG-B

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 473 088 997 SEK
Operating Margin TTM 32.04 %
PE Ratio 31.7365
Return On Assets TTM 13.62 %
PEG Ratio
Return On Equity TTM 18.69 %
Wall Street Target Price 1 811.5 SEK
Revenue TTM 1 355 662 976 SEK
Book Value 16.01 SEK
Revenue Per Share TTM
Dividend Share 1.9 SEK
Quarterly Revenue Growth YOY -4.3 %
Dividend Yield 1.83 %
Gross Profit TTM 801 929 000 SEK
Earnings per share 3.34 SEK
Diluted Eps TTM 3.34 SEK
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY -64.2 %
Profit Margin 24.85 %

Dividend Analytics BIOG-B

Dividend growth over 5 years

68 %

Continuous growth

2 years

Payout Ratio 5 years average

34 %

Dividend History BIOG-B

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 1.9
Ex Dividend Date 08.05.2024
Forward Annual Dividend Yield 1.79 %
Last Split Factor 5:1
Payout Ratio 56.89 %
Last Split Date 18.05.2022
Dividend Date

Stock Valuation BIOG-B

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 31.7365
Forward PE
Enterprise Value Revenue 7.2072
Price Sales TTM 8.0293
Enterprise Value EBITDA 19.0995
Price Book MRQ 6.72

Financials BIOG-B

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BIOG-B

For 52 weeks

94.58 SEK 136.6 SEK
50 Day MA 109.69 SEK
Shares Short Prior Month
200 Day MA 120.28 SEK
Short Ratio
Shares Short
Short Percent